Two Cases of Severe Cytomegalovirus Disease in Nontransplant Pediatric Acute Lymphoblastic Leukemia Patients Treated With Tyrosine Kinase Inhibitors

View at publisher Summarise with VIRAT
Authors: Irvin Yi, Michelle Foley, Aron Flagg, Stephanie Ann Massaro, Daniel Prior
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Cytomegalovirus (CMV) disease is a rare but significant complication among nontransplant pediatric leukemia patients. CMV infection has been observed in patients receiving tyrosine kinase inhibitors (TKIs) indicated for the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive (Ph+), and Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL). However, there is limited published data regarding CMV disease in nontransplant leukemia patients treated with TKIs. OBSERVATIONS: We present 2 cases of severe CMV disease in Ph+ and Ph-like ALL patients treated with TKI plus chemotherapy without transplant. CONCLUSIONS: We highlight this uncommon but serious adverse event in the pediatric population.

Fields of Study & Subjects

Cytomegalovirus and herpesvirus research Acute Lymphoblastic Leukemia research Neutropenia and Cancer Infections

Publication details

Journal / source
Journal of Pediatric Hematology/Oncology
Volume
48
Issue
4
Pages
201–206
Publication date
20 March 2026
Language
EN